INDV:NASDAQ
Indivior Pharmaceuticals Inc
$36.18
arrow_upward
+0.78%(+0.28) 1D
Oct 7, 3:07:45 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INDV...
Open
$35.58
High
$36.30
Low
$35.58
Mkt. cap
4.27B
Avg. vol.
2.01M
Volume
426.44K
P/E ratio
13.02
52-wk high
$42.81
52-wk low
$23.14
EPS
$2.78
Beta
1.10
Shares outstanding
118.03M
No. of employees
833
Open
$35.58
High
$36.30
Low
$35.58
Mkt. cap
4.27B
Avg. vol.
2.01M
Volume
426.44K
P/E ratio
13.02
52-wk high
$42.81
52-wk low
$23.14
EPS
$2.78
Beta
1.10
Shares outstanding
118.03M
No. of employees
833
News stories
From web sources and news partners
Stock Titan
·
1 day ago
A $1B special dividend features in Indivior (INDV)'s revised merger valuation details.
TipRanks
·
1 day ago
Indivior, Supernus advance merger amid disclosure updates
AD HOC NEWS
·
1 day ago
Indivior stock pre-market at EUR 32.10: plus 0.00 percent
Profile
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
About Indivior Pharmaceuticals Inc
CEOMark Crossley
Employees833
FoundedSep 26, 2014
Headquarters-
SectorPharmaceutical industry
Websiteindivior.com